CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.16B, above the global median of $1.15B
- FinancialsAltman Z-Score 2.6: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.22%Below 5Y avg (0.48%)
Annual Rate
CNY 0.05Paid annual
Payout Ratio
17.6%Sustainable
Last Ex-Dividend
Jun 2, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.79BCNY1.16B · vs all stocks (USD)
Trailing P/E
80.36xRevenue (TTM)
3.11BCNY462.41M · vs all stocks (USD)
Profit Margin
3.07%Beta
0.2410xvs all stocks
52-Week Change
-19.21%vs all stocks
Market Capitalization
7.79BCNY1.16B · vs all stocks (USD)
Enterprise Value
9.03BCNY1.34B · vs all stocks (USD)
Trailing P/E
80.36xForward P/E
35.71xPrice to Sales (TTM)
2.51xPrice to Book (MRQ)
2.13xEnterprise to Revenue
2.90xEnterprise to EBITDA
17.22xGross Margin
32.44%Profit Margin
3.07%Operating Margin
10.42%Return on Assets (TTM)
1.65%Return on Equity (TTM)
2.63%Revenue (TTM)
3.11BCNY462.41M · vs all stocks (USD)
Revenue per Share (TTM)
9.14CNYUpdated Aug 20, 2026Quarterly Revenue Growth
6.90%Gross Profit (TTM)
1.04BCNY155.09M · vs all stocks (USD)
EBITDA (TTM)
653.10MCNY97.00M · vs all stocks (USD)
Net Income (TTM)
95.72MCNY14.22M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-51.00%Operating Cash Flow (TTM)
588.63MCNY87.42M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
125.93MCNY18.70M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0500CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
0.22%vs all stocks
5-Year Average Dividend Yield
0.48%vs all stocks
Payout Ratio
17.64%Revenue
3.06BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.93BCNYFY2025 · Dec 31, 2025Gross Profit
1.14BCNYFY2025 · Dec 31, 2025Operating Income
304.40MCNY45.21M · vs all stocks (USD)
Pre-tax Income
158.60MCNYFY2025 · Dec 31, 2025Income Tax Expense
18.89MCNYFY2025 · Dec 31, 2025Net Income
139.71MCNYFY2025 · Dec 31, 2025EBIT
201.73MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
653.10MCNYFY2025 · Dec 31, 2025Research & Development
240.31MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
224.38MCNYFY2025 · Dec 31, 2025Other Operating Expenses
36.47MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
6.87MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
43.13MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.4100CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.4100CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
340.76MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
340.76MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
139.71MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
118.19MCNYFY2025 · Dec 31, 2025Free Cash Flow
-234.86MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
382.25MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
139.71MCNYFY2025 · Dec 31, 2025Other Non-cash Items
43.52MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-167.82MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
102.77MCNYFY2025 · Dec 31, 2025Capital Expenditures
-353.05MCNYFY2025 · Dec 31, 2025Purchase of Investments
-20.00MCNYFY2025 · Dec 31, 2025Sale of Investments
299.24KCNYFY2025 · Dec 31, 2025Other Investing Activity
2.44MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-370.31MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
2.12BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-2.18BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-57.96MCNYFY2025 · Dec 31, 2025Other Financing Charges
-3.83MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-122.03MCNYFY2025 · Dec 31, 2025Shares Outstanding
347.98MSharesUpdated Aug 20, 2026Float Shares
159.88MSharesUpdated Aug 20, 2026% Held by Insiders
53.46%vs all stocks
% Held by Institutions
14.38%vs all stocks
Total Cash (MRQ)
572.50MCNY85.03M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.65CNYUpdated Aug 20, 2026Total Debt (MRQ)
1.78BCNY264.22M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.4832xCurrent Ratio (MRQ)
1.19xBook Value per Share (MRQ)
10.58CNYUpdated Aug 20, 2026Total Assets
6.59BCNY978.63M · vs all stocks (USD)
Total Current Assets
3.01BCNYFY2025 · Dec 31, 2025Total Liabilities
2.95BCNYFY2025 · Dec 31, 2025Total Non-current Assets
3.58BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
323.64MCNYFY2025 · Dec 31, 2025Total Current Liabilities
2.63BCNYFY2025 · Dec 31, 2025Cash
381.84MCNYFY2025 · Dec 31, 2025Cash Equivalents
130.41MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
512.25MCNYFY2025 · Dec 31, 2025Other Short-term Investments
798.90KCNYFY2025 · Dec 31, 2025Accounts Receivable
556.85MCNYFY2025 · Dec 31, 2025Inventory
1.71BCNYFY2025 · Dec 31, 2025Accounts Payable
867.35MCNYFY2025 · Dec 31, 2025Short-term Debt
1.54BCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.36MCNYFY2025 · Dec 31, 2025Long-term Debt
226.89MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
16.77MCNYFY2025 · Dec 31, 2025Common Stock (Book)
347.98MCNYFY2025 · Dec 31, 2025Retained Earnings
1.78BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.64BCNY540.56M · vs all stocks (USD)
Treasury Stock
44.69MCNYFY2025 · Dec 31, 202552-Week Low
17.98CNYUpdated Aug 20, 202652-Week High
28.50CNYUpdated Aug 20, 202652-Week Change
-19.21%vs all stocks
Beta
0.2410xvs all stocks
50-Day MA
20.75CNYUpdated Aug 20, 2026200-Day MA
22.72CNYUpdated Aug 20, 2026Avg 10-Day Volume
4.29MSharesUpdated Aug 20, 2026Avg 30-Day Volume
4.04MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.2800CNYUpdated Aug 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.6: grey zoneSignificant
Altman Z-Score: 2.60
Low earnings qualitySignificant
Earnings Quality Score: -3.95
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.16B, above the global median of $1.15BNotable
Market cap (USD): 1,156,633,484.049Global Median: 1,146,734,693.424
Levered free cash flow is $18.7M, above the global median of $16.24MNotable
Levered free cash flow (USD): 18,703,635.697Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Eton Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shantou Institute of Ultrasonic Instruments Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
MeiraGTx Holdings plc
Tier 1ProductionApproval-Gated PipelineRuleRisk
BioGaia AB
Tier 1ProductionApproval-Gated PipelineRuleFlow
Sanofi Consumer Healthcare Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Northeast Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Sino Medical Sciences Technology Inc.
Tier 1ProductionApproval-Gated PipelineRule
Guilin Sanjin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Glass House Brands Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule
Innovita Biological Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule